A systematic review of the factors affecting accuracy of SUV measurements
…, TG Turkington, JM Wilson, TZ Wong - American Journal of …, 2010 - Am Roentgen Ray Soc
OBJECTIVE. There is growing interest in using PET/CT for evaluating early response to
therapy in cancer treatment. Although widely available and convenient to use, standardized …
therapy in cancer treatment. Although widely available and convenient to use, standardized …
[HTML][HTML] Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study
…, P Shellito, BG Czito, TZ Wong… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
… Wong, Erik Paulson, Martin Poleski, Zeljko Vujaskovic, Rex Bentley, Jeffrey W. Clark,
Rakesh K. Jain … Wong, Erik Paulson, Martin Poleski, Zeljko Vujaskovic, Rex Bentley …
Rakesh K. Jain … Wong, Erik Paulson, Martin Poleski, Zeljko Vujaskovic, Rex Bentley …
The incidence and functional consequences of RT-associated cardiac perfusion defects
…, M Blazing, D Hollis, P Lind, A Tisch, TZ Wong… - International Journal of …, 2005 - Elsevier
Purpose: Radiation therapy (RT) for left-sided breast cancer has been associated with
cardiac dysfunction. We herein assess the temporal nature and volume dependence of RT-…
cardiac dysfunction. We herein assess the temporal nature and volume dependence of RT-…
Clinical experience with α-particle–emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6
…, HS Friedman, RE McLendon, TZ Wong… - Journal of Nuclear …, 2008 - Soc Nuclear Med
α-Particle–emitting radionuclides, such as 211 At, with a 7.2-h half-life, may be optimally
suited for the molecularly targeted radiotherapy of strategically sensitive tumor sites, such as …
suited for the molecularly targeted radiotherapy of strategically sensitive tumor sites, such as …
Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit
…, C Martin, T Moriarty, A Nabavi, TZ Wong… - …, 1999 - journals.lww.com
OBJECTIVE: The complex three-dimensional anatomic features of the brain and its vulnerability
to surgical intervention make the surgical treatment of intracranial tumors challenging. …
to surgical intervention make the surgical treatment of intracranial tumors challenging. …
Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly …
…, TD Shafman, CJ Wikstrand, TZ Wong… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: To assess the efficacy and toxicity of intraresection cavity 131 I-labeled murine
antitenascin monoclonal antibody 81C6 and determine its true response rate among patients …
antitenascin monoclonal antibody 81C6 and determine its true response rate among patients …
Positron emission tomography imaging of brain tumors
TZ Wong, GJ van der Westhuizen… - Neuroimaging …, 2002 - neuroimaging.theclinics.com
Positron emission tomography (PET) imaging provides in vivo biochemical and physiological
data and therefore can provide unique functional information about tumors compared with …
data and therefore can provide unique functional information about tumors compared with …
Salvage radioimmunotherapy with murine iodine-131–labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant …
…, M Badruddoja, JM Dowell, TZ Wong… - Journal of clinical …, 2006 - ascopubs.org
Purpose To assess the efficacy and toxicity of intraresection cavity iodine-131–labeled murine
antitenascin monoclonal antibody 81C6 ( 131 I-m81C6) among recurrent malignant brain …
antitenascin monoclonal antibody 81C6 ( 131 I-m81C6) among recurrent malignant brain …
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
…, JM Provenzale, DA Reardon, TZ Wong… - Neuro …, 2008 - academic.oup.com
The purpose of this study is to determine the maximum tolerated dose (MTD), dose-limiting
toxicity (DLT), and intracerebral distribution of a recombinant toxin (TP-38) targeting the …
toxicity (DLT), and intracerebral distribution of a recombinant toxin (TP-38) targeting the …
Prospective assessment of radiotherapy‐associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment
…, X Yu, MA Blazing, DR Hollis, A Tisch, TZ Wong… - Cancer, 2007 - Wiley Online Library
BACKGROUND. Radiation therapy (RT) to the left breast/chest wall has been linked with
cardiac dysfunction. Previously, the authors identified cardiac perfusion defects in …
cardiac dysfunction. Previously, the authors identified cardiac perfusion defects in …